How much funding has Galvanize Therapeutics raised?

Galvanize Therapeutics has raised $210.0M in total funding, most recently a Series C round.

When was Galvanize Therapeutics founded?

Galvanize Therapeutics was founded in 2015.

Where is Galvanize Therapeutics headquartered?

Galvanize Therapeutics is headquartered in Redwood City, California, United States.

What industry is Galvanize Therapeutics in?

Galvanize Therapeutics operates in Medical Devices, Medtech, Oncology, Pulsed Field Ablation, Healthcare.

How many employees does Galvanize Therapeutics have?

Galvanize Therapeutics has 51-200 employees.

Galvanize Therapeutics

Q: Who are Galvanize Therapeutics's investors?

Galvanize Therapeutics's investors include Sofinnova Partners, Fidelity Management, Apple Tree Partners.

Galvanize

Redwood City, United States · Founded 2015 · $210.0M raised

Medical Devices

Medtech

Oncology

Pulsed Field Ablation

Healthcare

Headquarters: Redwood City, California
Employees: 51–200
Founded: 2015
Business Model: B2B

Website: galvanizetx.com
Total Funding: $210.0M
Last Round: $100.0M Series CSep 2025
Rounds: 3

About

Galvanize Therapeutics is a medical device company developing Pulsed Electric Field (PEF) systems that use high-voltage, short-duration electrical energy to disrupt target cell membranes and modulate biologic processes. Its lead product, the Aliya PEF System, is being evaluated for oncology indications including lung cancer, as well as chronic bronchitis and drug delivery applications. The company has conducted extensive clinical research demonstrating local tumor control and potential immune activation.

Summary

Galvanize Therapeutics is a Medical Devices company based in Redwood City, United States, founded in 2015. It has raised $210.0M in total across 3 rounds, most recently a $100.0M Series C round in Sep 2025. Investors include Sofinnova Partners, Fidelity Management and Apple Tree Partners.

LinkedIn X (Twitter)